Details for New Drug Application (NDA): 206996
✉ Email this page to a colleague
The generic ingredient in PIPERACILLIN AND TAZOBACTAM is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 206996
Tradename: | PIPERACILLIN AND TAZOBACTAM |
Applicant: | Wockhardt Bio Ag |
Ingredient: | piperacillin sodium; tazobactam sodium |
Patents: | 0 |
Pharmacology for NDA: 206996
Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 206996
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 206996 | ANDA | Wockhardt USA LLC. | 64679-012 | 64679-012-01 | 10 VIAL, SINGLE-USE in 1 CARTON (64679-012-01) / 20 mL in 1 VIAL, SINGLE-USE (64679-012-02) |
PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 206996 | ANDA | Wockhardt USA LLC. | 64679-034 | 64679-034-01 | 10 VIAL, SINGLE-USE in 1 CARTON (64679-034-01) / 10 mL in 1 VIAL, SINGLE-USE (64679-034-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | ||||
Approval Date: | Mar 22, 2017 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | ||||
Approval Date: | Mar 22, 2017 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | ||||
Approval Date: | Mar 22, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription